Long-Term Efficacy and Safety of Celecoxib in Alzheimer’s Disease

Abstract

Celecoxib 200 mg bid did not slow the progression of AD in this study, and the occurrence of adverse events was as expected for an elderly population with a complex chronic medical condition.